Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: SOBI 2025 Outlook Unchanged

April 29 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

Q1 REVENUE SEK 6,465 MILLION VERSUS. IBES ESTIMATE SEK 6,267 MILLION

Q1 EBIT SEK 1,358 MILLION

Q1 ADJUSTED FREE CASH FLOW SEK 2,295 MILLION

Q1 ADJUSTED EPS SEK 2.55

2025 OUTLOOK UNCHANGED

ON TARIFFS: TARIFFS ARE PARTLY PAUSED, POTENTIAL FUTURE IMPACT CANNOT BE ESTIMATED AT THIS POINT

Source text: ID:nWkr63gPCQ

Further company coverage: SOBIV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Swedish Orphan Biovitrum AB (publ)

See all news